Latest Cost Savings News

Coronado Global Resources has strengthened its financial position with a $150 million liquidity injection and a pivotal five-year coal supply agreement with Stanwell Corporation, reshaping its export potential from 2027.

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Yojee Limited and SmartClear have completed technical verification of their MOSAIC platform, a next-generation freight forwarding and customs messaging solution compliant with Australian and New Zealand customs regulations. This milestone sets the stage for a strategic partnership aimed at transforming logistics technology in the region.

Solis Minerals is set to delist from the TSX Venture Exchange, consolidating its primary listing on the ASX and planning a re-domiciliation to Australia to sharpen its focus on copper-gold exploration in Peru.

DGL Group projects a challenging FY25 with profits down sharply despite steady revenue, as it undertakes major cost realignment and operational integration to set the stage for future growth.

Dubber Corporation has confirmed it will retain its key contract with Virgin Media O2, securing guaranteed revenues for FY26 while implementing significant cost reductions to return to cash flow positivity by year-end.

Eden Innovations Ltd reports a striking 86% year-on-year sales increase for its EdenCrete® Pz7 concrete admixture, driven by expanding installations in the US, Ecuador, Mexico, and Canada. The company’s innovative product is gaining traction for its cost-saving and environmental benefits in the construction sector.

Myer Holdings has unveiled a comprehensive strategic transformation plan, integrating its recent Apparel Brands acquisition and leveraging a strengthened balance sheet to drive sustained earnings growth. The company aims to redefine its retail presence through customer-centric innovation and operational efficiency.

ALS Limited delivered a robust FY25 performance with 16% revenue growth to $3 billion and underlying EBIT rising 4.7% to $515 million, driven by strong organic growth and strategic acquisitions. The company is advancing its Nuvisan integration ahead of schedule and has unveiled a $230 million investment plan to expand key laboratories, positioning itself for sustained growth amid market uncertainties.

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.

ALS Limited reported a 16% revenue increase to nearly $3 billion in FY2025, driven by acquisitions and organic growth, while underlying net profit after tax dipped slightly. The company announced a $350 million equity raise to fund expansion and sustainability initiatives.

Nufarm Limited confirms its half-year earnings align closely with analyst expectations despite a late-stage $16 million inventory valuation adjustment. The company maintains compliance with ASX disclosure rules amid market scrutiny.